Britannia Life Sciences Inc (BLAB)

The most recent insider trading activity for Britannia Life Sciences Inc. occurred on March 11, 2026. Director and senior officer Peter James Shippen executed a purchase of 20,000 shares valued at $1,900. There have been no other reported insider transactions within the last three months.
Ticker: BLAB Exchange: CNX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 11 Mar 2026
Value CA$2,179,757.05 | Price 296.48 | Shares 48,166 (+11.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-11 2026-03-11 B Purchase

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
48,166 +11.0%
296.48
CA$2,179,757
48,166 +11.0% 296.48 CA$2,179,757